Synlett 2019; 30(19): 2131-2135
DOI: 10.1055/s-0039-1690227
letter
© Georg Thieme Verlag Stuttgart · New York

Base-Controlled One-Pot Chemoselective Suzuki–Miyaura Reactions for the Synthesis of Unsymmetrical Terphenyls

Xinmin Li
School of Pharmacy, Zunyi Medical University, Zunyi, 563000, P. R. of China   eMail: lixm@zmu.edu.cn
,
Fangfang Feng
,
Changyue Ren
,
Yong Teng
,
Qinghong Hu
,
Zeli Yuan
School of Pharmacy, Zunyi Medical University, Zunyi, 563000, P. R. of China   eMail: lixm@zmu.edu.cn
› Institutsangaben
This work was financially supported by NSFC (81660575 and 81360471), the United Scientific Research Foundation of Zunyi Medical University (E-234), and the Natural Science and Technology Foundation of Guizhou Province ([2018]1187).
Weitere Informationen

Publikationsverlauf

Received: 29. August 2019

Accepted after revision: 14. Oktober 2019

Publikationsdatum:
04. November 2019 (online)


Abstract

We report a chemoselective Suzuki–Miyaura reaction protocol of using bromophenyl fluorosulfonate as building block for the preparation of unsymmetrical terphenyls. The chemoselective cross-coupling of bromophenyl fluorosulfonate and arylboronic acids can be achieved by controlling base species without using any ligands. Under this methodology, various of m- and p-unsymmetrical terphenyls were obtained in moderate to good yields.

Supporting Information

 
  • References and Notes

    • 6a Antelo Miguez JM, Adrio LA, Sousa-Pedrares A, Vila JM, Hii KK. J. Org. Chem. 2007; 72: 7771
    • 6b Kawada K, Arimura A, Tsuri T, Fuji M, Komurasaki T, Yonezawa S, Kugimiya A, Haga N, Mitsumori S, Inagaki M, Nakatani T, Tamura Y, Takechi S, Taishi T, Kishino J, Ohtani M. Angew. Chem. Int. Ed. 1998; 37: 973
  • 8 Taylor RH, Felpin F.-X. Org. Lett. 2007; 9: 2911
  • 9 Kazi SA, Campi EM, Hearn MT. Tetrahedron 2018; 74: 1731
  • 10 Li X, Liu C, Wang L, Ye Q, Jin X, Jin Z. Org. Biomol. Chem. 2018; 16: 8719
  • 11 Dong J, Krasnova L, Finn MG, Sharpless KB. Angew. Chem. Int. Ed. 2014; 53: 9430
  • 14 General Procedure for the Preparation of Biaryl Fluorosulfonates A mixture of bromophenyl fluorosulfonates (0.5 mmol), arylboronic acid (0.55 mmol), K2CO3 (1 mmol), Pd(OAc)2 (1 mol%), and EtOH/H2O (2 mL/2 mL) was stirred at 25 °C under air for the indicated time. After the reaction, the mixture was added to brine (10 mL) and extracted with ethyl acetate (3 × 15 mL). The combined organic layers were concentrated in vacuo, and the product was isolated by short chromatography on a silica gel (200–300 mesh) column using petroleum ether (60–90 °C). 3′,4′-Dimethoxybiphenyl-4-yl fluorosulfate (2f) Colorless liquid (140.8 mg, 90%). 1H NMR (400 MHz, CDCl3): δ = 7.62 (d, J = 6.4 Hz, 2 H), 7.38 (d, J = 6.7 Hz, 2 H), 7.08 (d, J = 19.1 Hz, 2 H), 6.96 (s, 1 H), 3.93 (s, 6 H). 13C NMR (101 MHz, CDCl3): δ = 149.3, 149.2, 149.0, 141.8, 132.1, 128.6, 121.1, 119.6, 111.5, 110.3, 55.9. 19F NMR (376 MHz, CDCl3): δ = 37.4 (s, 1 F). 3′,4′-Dimethoxybiphenyl-3-yl fluorosulfate (2m) Colorless liquid (140.1 mg, 89%). 1H NMR (400 MHz, CDCl3): δ = 7.50 (d, J = 7.8 Hz, 1 H), 7.40 (s, 2 H), 7.18 (d, J = 7.3 Hz, 1 H), 7.03 (d, J = 8.2 Hz, 1 H), 6.97 (s, 1 H), 6.86 (d, J = 8.3 Hz, 1 H), 3.84 (d, J = 11.5 Hz, 6 H). 13C NMR (101 MHz, CDCl3): δ = 150.4, 149.4, 149.3, 143.8, 131.6, 130.5, 126.8, 119.60, 118.9, 118.6, 111.5, 110.1, 55.9. 19F NMR (376 MHz, CDCl3): δ = 37.1 (s, 1 F).
  • 15 General Procedure for the Preparation of Unsymmetrical Terphenyls A mixture of bromophenyl fluorosulfonate (0.5 mmol), arylboronic acid (0.5 mmol), K2CO3 (1 mmol), Pd(OAc)2 (1 mol%), and EtOH/H2O (5 mL/5 mL) was stirred at 25 °C under air for 0.5 h. Then, arylboronic acid (0.5 mmol), (i-Pr)2NH (1 mmol), and Pd(OAc)2 (1 mol%) were added to the reaction mixture and stirred for 3.5 h at 80 °C. Afterwards, the mixture was cooled to room temperature and concentrated in vacuo. The terphenyl product was isolated by short chromatography on a silica gel (200–300 mesh) column using petroleum ether and ethyl acetate. 4′′-Fluoro-3,4-dimethoxy-1,1′:4′,1′′-terphenyl (3l) White solid (126.7 mg, 82%); mp 149–150 °C. 1H NMR (400 MHz, CDCl3): δ = 7.69–7.51 (m, 6 H), 7.19 (dd, J = 8.3, 2.1 Hz, 1 H), 7.17–7.10 (m, 3 H), 6.97 (d, J = 8.3 Hz, 1 H), 3.97 (s, 3 H), 3.94 (s, 3 H). 13C NMR (101 MHz, CDCl3): δ = 149.2, 148.7, 139.9, 138.7, 133.6, 128.5, 128.5, 127.3, 127.2, 119.3, 115.8, 115.5, 111.5, 110.3, 56.0, 55.9. 5-[3′,4′-Dimethoxy-(1,1′-biphenyl)-4-yl]pyrimidine (3v) White solid (50.2 mg, 38%); mp 85–86 °C. 1H NMR (400 MHz, CDCl3): δ = 9.18 (d, J = 21.5 Hz, 1 H), 8.96 (d, J = 32.8 Hz, 2 H), 7.68 (dd, J = 27.4, 8.2 Hz, 3 H), 7.56 (dd, J = 24.1, 8.4 Hz, 2 H), 7.03 (dd, J = 12.6, 8.8 Hz, 2 H), 3.87 (s, 3 H). 13C NMR (101 MHz, CDCl3): δ = 160.4, 159.5, 157.3, 156.8, 154.6, 154.4, 141.5, 133.9, 132.4, 132.3, 128.1, 127.6, 127.2, 114.9, 114.3, 55.3.